Equasens: down on nine-month sales

(CercleFinance.com) - Equasens is down by more than 5% following the announcement by the software and hardware solutions group for the healthcare sector of sales of 158.
2 million euros to end September, down by 2.8% (-4.9% on a like-for-like basis).

However, it claims 'a more favorable dynamic in the third quarter on a reported basis (+0.3%) and on a like-for-like basis (-3%), with a recovery in all divisions except AXIGATE LINK, which has been growing since the beginning of the year'.

In terms of outlook, Equasens remains confident that growth will resume in the last quarter of 2024, and is 'actively seeking external growth opportunities in France and Europe to strengthen its position in its markets'.

Copyright (c) 2024 CercleFinance.com. All rights reserved.